According to ImmunoPrecise Antibodies's latest financial reports the company's current earnings are NZ$17.17 Million. In 2024 the company made an earning of -NZ$60.57 Million a decrease over its 2023 earnings that were of -NZ$19.42 Million. The earnings displayed on this page is the company's Pretax Income.